Resumen de acción CL
Colgate-Palmolive Company, junto con sus filiales, fabrica y vende productos de consumo en Estados Unidos y a escala internacional.
Puntuación del snowflake | |
---|---|
Valoración | 4/6 |
Crecimiento futuro | 2/6 |
Rendimiento pasado | 4/6 |
Salud financiera | 4/6 |
Dividendos | 5/6 |
Community Narratives
Narratives bring a range of perspectives from our community.
Strategies To Spark Revenue And Earnings Growth Amidst Global Market Challenges
Competidores de Colgate-Palmolive Company
Historial de precios y rendimiento
Precios históricos de las acciones | |
---|---|
Precio actual de la acción | US$106.13 |
Máximo en las últimas 52 semanas | US$109.30 |
Mínimo de 52 semanas | US$67.62 |
Beta | 0.40 |
1Cambio en 1 mes | 4.79% |
Variación en 3 meses | 12.00% |
Cambio de 1 año | 45.72% |
3Variación en 3 años | 37.46% |
Variación en 5 años | 50.01% |
Variación desde la OPV | 11,379.98% |
Noticias y actualizaciones recientes
These 4 Measures Indicate That Colgate-Palmolive (NYSE:CL) Is Using Debt Reasonably Well
Sep 11Returns At Colgate-Palmolive (NYSE:CL) Appear To Be Weighed Down
Aug 27Colgate-Palmolive: Stability Pillar Reached Its Fair Value
Aug 19An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 31% Undervalued
Aug 12Colgate-Palmolive: Good Growth Prospects Ahead
Aug 06Recent updates
These 4 Measures Indicate That Colgate-Palmolive (NYSE:CL) Is Using Debt Reasonably Well
Sep 11Returns At Colgate-Palmolive (NYSE:CL) Appear To Be Weighed Down
Aug 27Colgate-Palmolive: Stability Pillar Reached Its Fair Value
Aug 19An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 31% Undervalued
Aug 12Colgate-Palmolive: Good Growth Prospects Ahead
Aug 06Earnings Not Telling The Story For Colgate-Palmolive Company (NYSE:CL)
Jul 11Colgate-Palmolive: Three Items To Look For In The Upcoming Earnings
Jul 10Colgate-Palmolive: Gladly Holding, Yet Currently Not Buying An All Time Favorite
Jun 23Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Jun 06Many Would Be Envious Of Colgate-Palmolive's (NYSE:CL) Excellent Returns On Capital
May 21Analysts Have Made A Financial Statement On Colgate-Palmolive Company's (NYSE:CL) First-Quarter Report
Apr 30Colgate-Palmolive: Loading Up Ahead Of Earnings
Apr 16Why Investors Shouldn't Be Surprised By Colgate-Palmolive Company's (NYSE:CL) P/E
Apr 02Colgate-Palmolive's (NYSE:CL) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 18Is Colgate-Palmolive Company (NYSE:CL) Trading At A 33% Discount?
Feb 14Colgate-Palmolive: I'm Buying Before Interest Rates Decrease
Feb 14Colgate-Palmolive: Brushing Up Profits In Q4 2023
Jan 30Is Colgate-Palmolive (NYSE:CL) A Risky Investment?
Jan 19Getting In Cheap On Colgate-Palmolive Company (NYSE:CL) Might Be Difficult
Jan 01Colgate-Palmolive: A Better Year Ahead (Rating Upgrade)
Dec 20Colgate-Palmolive Stock And Its Real Value
Nov 29Brush Up With Colgate-Palmolive Stock As Earnings Growth Drips On
Nov 14Colgate-Palmolive (NYSE:CL) Will Want To Turn Around Its Return Trends
Nov 06Colgate-Palmolive: Own This Dividend King At The Right Price
Oct 31Why Colgate-Palmolive Is A Bargain You Shouldn't Ignore Right Now
Oct 13Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Oct 02Colgate-Palmolive: Dividend King With Limited Growth
Sep 27An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 34% Undervalued
Sep 11Colgate-Palmolive: Improving Prospects And A Reasonable Valuation
Sep 09Colgate-Palmolive: A Healthy 7% Return With A Safe Dividend For Investors In A Post-Pandemic World
Aug 16Colgate And The Importance Of Sales Growth, Expectations Matter
Aug 09Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business
Aug 03Colgate-Palmolive: Challenging Growth Prospects
Jul 10Colgate-Palmolive (NYSE:CL) Is Increasing Its Dividend To $0.48
Jun 27Colgate-Palmolive (NYSE:CL) Will Pay A Larger Dividend Than Last Year At $0.48
Jun 13Colgate-Palmolive: The Reasons We Are Becoming More Cautious
Jun 05Here's Why Colgate-Palmolive (NYSE:CL) Can Manage Its Debt Responsibly
Jun 05Calculating The Intrinsic Value Of Colgate-Palmolive Company (NYSE:CL)
May 18Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Feb 23Calculating The Fair Value Of Colgate-Palmolive Company (NYSE:CL)
Feb 05Rentabilidad de los accionistas
CL | US Household Products | Mercado US | |
---|---|---|---|
7D | -2.4% | 1.5% | -0.8% |
1Y | 45.7% | 16.4% | 20.5% |
Rentabilidad vs. Industria: CL superó a la industria US Household Products, que obtuvo un rendimiento del 12.7% el año pasado.
Rentabilidad vs. Mercado: CL superó al mercado US, que obtuvo un rendimiento del 22.3% el año pasado.
Volatilidad de los precios
CL volatility | |
---|---|
CL Average Weekly Movement | 2.2% |
Household Products Industry Average Movement | 3.2% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.1% |
10% least volatile stocks in US Market | 3.1% |
Precio estable de las acciones: CL no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de CL (2%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
Fundada | Empleados | CEO | Página web |
---|---|---|---|
1806 | 34,000 | Noel Wallace | www.colgatepalmolive.com |
Colgate-Palmolive Company, junto con sus filiales, fabrica y vende productos de consumo en Estados Unidos y a escala internacional. Opera a través de dos segmentos: Cuidado Oral, Personal y del Hogar; y Nutrición de Mascotas. El segmento de Cuidado Oral, Personal y del Hogar ofrece dentífricos, cepillos de dientes, enjuagues bucales, jabones de manos líquidos y en barra, geles de ducha, champús, acondicionadores, desodorantes y antitranspirantes, productos para la salud de la piel, detergentes lavavajillas, acondicionadores de tejidos, limpiadores domésticos y otros artículos relacionados.
Resumen de fundamentos de Colgate-Palmolive Company
Estadísticas fundamentales de CL | |
---|---|
Capitalización bursátil | US$86.72b |
Beneficios(TTM) | US$2.84b |
Ingresos (TTM) | US$19.99b |
30.5x
Ratio precio-beneficio (PE)4.3x
Ratio precio-ventas (PS)¿Está CL sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
Cuenta de resultados (TTM) de CL | |
---|---|
Ingresos | US$19.99b |
Coste de los ingresos | US$8.06b |
Beneficio bruto | US$11.93b |
Otros gastos | US$9.09b |
Beneficios | US$2.84b |
Últimos beneficios comunicados
Jun 30, 2024
Próxima fecha de beneficios
n/a
Beneficios por acción (BPA) | 3.48 |
Margen bruto | 59.70% |
Margen de beneficio neto | 14.21% |
Ratio deuda/patrimonio | 1,800.0% |
¿Cómo se ha desempeñado CL a largo plazo?
Ver rendimiento histórico y comparativa